Study of ART0380 in Patients With Biologically Selected Solid Tumors

Clinical trial NCT05798611 · TERMINATED

Trial details

NCT number: NCT05798611
Sponsor: Artios Pharma Ltd
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Recurrent Endometrial Cancer Metastatic Cancer

Start date: 2023-09-06
Primary completion: 2024-11-15
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.